Skip to main content
Top
Published in: Rheumatology International 10/2012

01-10-2012 | Short Communication

Dual anca positivity in a child with moyamoya-like cerebral vascular changes: an unusual presentation with sudden homonymous hemianopsia

Authors: Hale Sakalli, Esra Baskin, Füsun Alehan, Muhteşem Agıldere, Yonca Aydin Akova, Hakan Caner

Published in: Rheumatology International | Issue 10/2012

Login to get access

Abstract

A 12-year-old girl presented with a sudden decrease in her right visual acuity and homonymous hemianopsia. An angiography of the retinal arteries demonstrated recanalized occlusion of the right retinal artery. Cerebral angiography showed bilateral internal carotid artery stenosis associated with the development of collateral circulation. Laboratory evaluations revealed dual antineutrophil cytoplasmic antibodies (ANCA) positivity [anti-proteinase (anti-PR3) ANCA and anti-myeloperoxidase (anti-MPO) ANCA], anticardiolipin (aCL) antibodies, and low titers of antinuclear antibodies (ANA). There was no evidence of active systemic lupus erythematosus (SLE), ANCA-related vasculitis, or other risk factors for cerebral occlusion, such as antiphospholipid syndrome (APS). Dual positivity for both cytoplasmic (c-ANCA) and perinuclear (p-ANCA) antineutrophil antibodies has been found previously in a small number of reports, but to our knowledge, this case represents the first case of moyamoya disease associated with dual ANCA positivity.
Literature
1.
go back to reference El Ramahi KM, Al Rayes HM (2000) Systemic lupus erythematosus associated with moyamoya syndrome. Lupus 9:632–636PubMedCrossRef El Ramahi KM, Al Rayes HM (2000) Systemic lupus erythematosus associated with moyamoya syndrome. Lupus 9:632–636PubMedCrossRef
2.
go back to reference Fukui M, Kono S, Sueishi K, Ikezaki K (2000) Moyamoya disease. Neuropathology 20:61–64CrossRef Fukui M, Kono S, Sueishi K, Ikezaki K (2000) Moyamoya disease. Neuropathology 20:61–64CrossRef
3.
go back to reference Manceau E, Giroud M, Dumas R (1997) Moyamoya disease in children. Child’s Nerv Syst 13:595–600CrossRef Manceau E, Giroud M, Dumas R (1997) Moyamoya disease in children. Child’s Nerv Syst 13:595–600CrossRef
4.
go back to reference Sebban AI, Sullivan TJ, Davison MB (1997) Branch retinal artery occlusion in a child. Aust N Z J Ophthalmol 24:283–286CrossRef Sebban AI, Sullivan TJ, Davison MB (1997) Branch retinal artery occlusion in a child. Aust N Z J Ophthalmol 24:283–286CrossRef
5.
go back to reference Barrall JL, Summers CG (1996) Ocular ischemic syndrome in a child with moyamoya disease and neurofibromatosis. Surv Ophthalmol 40:500–504PubMedCrossRef Barrall JL, Summers CG (1996) Ocular ischemic syndrome in a child with moyamoya disease and neurofibromatosis. Surv Ophthalmol 40:500–504PubMedCrossRef
6.
go back to reference Wanifuchi H, Kagawa M, Takeshita M, Izawa M, Maruyama S, Kitamura K (1986) Auto-immune antibody in moyamoya disease (in Japanese). Neurosurgery 14:31–35 Wanifuchi H, Kagawa M, Takeshita M, Izawa M, Maruyama S, Kitamura K (1986) Auto-immune antibody in moyamoya disease (in Japanese). Neurosurgery 14:31–35
7.
go back to reference Fujiwara S, Miyazono M, Tsuda H, Fukui M (1993) Intraventricular hemorrhage and cerebral ischemic attacks in the presence of lupus anticoagulant mimicking moyamoya disease. J Neurosurg Sci 37:161–164PubMed Fujiwara S, Miyazono M, Tsuda H, Fukui M (1993) Intraventricular hemorrhage and cerebral ischemic attacks in the presence of lupus anticoagulant mimicking moyamoya disease. J Neurosurg Sci 37:161–164PubMed
8.
go back to reference Provost TT, Moses H, Morris EL, Altman J, Harley JB, Alexander E, Reichlin M (1991) Cerebral vasculopathy associated with anti-Ro/SSA and anti-La/SSB antibodies. Arthritis Rheum 34:1052–1055PubMedCrossRef Provost TT, Moses H, Morris EL, Altman J, Harley JB, Alexander E, Reichlin M (1991) Cerebral vasculopathy associated with anti-Ro/SSA and anti-La/SSB antibodies. Arthritis Rheum 34:1052–1055PubMedCrossRef
9.
go back to reference Pradhan VD, Badakere SS, Bichile LS, Almeida AF (2004) Anti-neutrophil cytoplasmic antibodies (ANCA) in systemic lupus erythematosus: prevalence, clinical associations and correlation with other autoantibodies. J Assoc Physicians India 52:533–537PubMed Pradhan VD, Badakere SS, Bichile LS, Almeida AF (2004) Anti-neutrophil cytoplasmic antibodies (ANCA) in systemic lupus erythematosus: prevalence, clinical associations and correlation with other autoantibodies. J Assoc Physicians India 52:533–537PubMed
10.
go back to reference Chin HJ, Ahn C, Lim CS, Chung HK, Lee JG, Song YW, Lee HS, Han JS, Kim S, Lee JS (2000) Clinical implications of antineutrophil cytoplasmic antibody test in lupus nephritis. Am J Nephrol 20:57–63PubMedCrossRef Chin HJ, Ahn C, Lim CS, Chung HK, Lee JG, Song YW, Lee HS, Han JS, Kim S, Lee JS (2000) Clinical implications of antineutrophil cytoplasmic antibody test in lupus nephritis. Am J Nephrol 20:57–63PubMedCrossRef
11.
go back to reference Baskin E, Agras PI, Menekse N, Ozdemir H, Cengiz N (2007) Full-house nephropathy in a patient with negative serology for lupus. Rheumatol Int 27:281–284PubMedCrossRef Baskin E, Agras PI, Menekse N, Ozdemir H, Cengiz N (2007) Full-house nephropathy in a patient with negative serology for lupus. Rheumatol Int 27:281–284PubMedCrossRef
12.
go back to reference Bakdash T, Cohen AR, Hempel JM, Hoagland J, Newman AJ (2002) Moyamoya, dystonia during hyperventilation, and antiphospholipid antibodies. Pediatr Neurol 26:157–160PubMedCrossRef Bakdash T, Cohen AR, Hempel JM, Hoagland J, Newman AJ (2002) Moyamoya, dystonia during hyperventilation, and antiphospholipid antibodies. Pediatr Neurol 26:157–160PubMedCrossRef
13.
go back to reference Booth F, Yanofsky R, Ross IB, Lawrence P, Oen K (1999) Primary antiphospholipid syndrome with moyamoya-like vascular changes. Pediatric Neurosurg 31:45–48CrossRef Booth F, Yanofsky R, Ross IB, Lawrence P, Oen K (1999) Primary antiphospholipid syndrome with moyamoya-like vascular changes. Pediatric Neurosurg 31:45–48CrossRef
14.
go back to reference Zhang X, Dong Y, Zeng X, Li Y, Tang F (2002) Clinical and pathological manifestations of patients with antineutrophil cytoplasmic autoantibodies directed against proteinase 3 or myeloperoxidase. Chin Med Sci J 17:32–35PubMed Zhang X, Dong Y, Zeng X, Li Y, Tang F (2002) Clinical and pathological manifestations of patients with antineutrophil cytoplasmic autoantibodies directed against proteinase 3 or myeloperoxidase. Chin Med Sci J 17:32–35PubMed
15.
go back to reference Guardiola JM, Rodriguez-Pla A, Lopez-Contreras J, Llobet JM, Domingo P, Franco M, Diaz C, Vazquez G (2000) Simultaneous presence of c-ANCA and p-ANCA in a patient with concurrent Churg-Strauss syndrome and giant cell temporal arteritis. Scand J Rheumatol 29:68–69PubMedCrossRef Guardiola JM, Rodriguez-Pla A, Lopez-Contreras J, Llobet JM, Domingo P, Franco M, Diaz C, Vazquez G (2000) Simultaneous presence of c-ANCA and p-ANCA in a patient with concurrent Churg-Strauss syndrome and giant cell temporal arteritis. Scand J Rheumatol 29:68–69PubMedCrossRef
16.
go back to reference Ferraz-Amaro I, Herrero MJ, Jurado A, Diaz-Gonzalez F (2004) Dual positivity for cytoplasmic and perinuclear anti-neutrophil antibodies in a patient with Henoch-Schönlein purpura. Clin Exp Rheumatol 22:233–234PubMed Ferraz-Amaro I, Herrero MJ, Jurado A, Diaz-Gonzalez F (2004) Dual positivity for cytoplasmic and perinuclear anti-neutrophil antibodies in a patient with Henoch-Schönlein purpura. Clin Exp Rheumatol 22:233–234PubMed
17.
go back to reference Tiliakos AM, Tiliakos NA (2008) Dual ANCA positivity in subacute bacterial endocarditis. J Clin Rheumatol 14:38–40PubMedCrossRef Tiliakos AM, Tiliakos NA (2008) Dual ANCA positivity in subacute bacterial endocarditis. J Clin Rheumatol 14:38–40PubMedCrossRef
Metadata
Title
Dual anca positivity in a child with moyamoya-like cerebral vascular changes: an unusual presentation with sudden homonymous hemianopsia
Authors
Hale Sakalli
Esra Baskin
Füsun Alehan
Muhteşem Agıldere
Yonca Aydin Akova
Hakan Caner
Publication date
01-10-2012
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 10/2012
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-011-2064-y

Other articles of this Issue 10/2012

Rheumatology International 10/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine